Carlyle Acquiring stake gives them a strong backbone which enables them to think about entering US or China market and lot of other optionality.
Filed First injectable (Tulathromycin) for US market.
Initiated CDMO business (optionality)

@itsTarH hey Tariq, any idea why is Sequent falling?
— Vivek (@pa_stock) September 27, 2021
Don't expect the earnings to go anywhere till FY23.
— Tar \u26a1 (@itsTarH) August 10, 2021
Real growth will only come post FY24.
I expect the stock to either correct or stay muted till then. https://t.co/lUQfzxojTO